Taking stock of the drug industry, from the lab to the medicine chest

May 22, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Lauren DeCicca/Getty Images FDA asks mRNA vaccine makers to widen age range for rare heart risk warning FDA asks Moderna and Pfizer-BioNTech to update warning labels on Covid-19 vaccines with expanded age range of men at risk for myocarditis. By Elizabeth Cooney Opinion: I'm a Republican former congressman and doctor. The new HHS placebo-controlled trial mandate is dangerous Placebo-controlled trials for all new vaccines, even when a proven vaccine for a disease already exists, are a violation of basic medical ethics. By Larry Bucshon STAT+ | FDA chief pushes back on senators' criticism, says Covid booster trials should take 'roughly a year' Makary told senators that staffing cuts haven't hindered the FDA's main missions. By Lizzy Lawrence Uncertainty in CRISPR world and the start of more M&A STAT reporters chat about the mood in the gene editing field, M&A deals in biotech, and leadership changes at Novo Nordisk. By Allison DeAngelis, Elaine Chen, and Adam Feuerstein STAT+ | Biotech investor activism is on the rise Investors should have more say in how their money is spent. Too often, management teams take a dismissive "we know better" attitude By Adam Feuerstein Opinion: The FDA is circumventing key roles and procedures for licensure and use of Covid vaccines Two people with limited expertise in vaccinology — Vinay Prasad and Marty Makary — are leading the FDA vaccine evaluation process. By Kathryn M. Edwards

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser